Skip to content

Spectral-domain Optical Coherence Tomography of the Eye

A Prospective, Comparative, Observational Study on Spectral-domain Optical Coherence Tomography of the Eye

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02614625
Enrollment
100
Registered
2015-11-25
Start date
2014-12-31
Completion date
2015-12-31
Last updated
2015-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cornea, Diabetes, Diabetic Macular Edema, Macular Edema, Refractive Surgery, Retina

Brief summary

An increasing number of clinical studies on SD-OCT of ocular pathologies and potential new clinical applications has recently been published in the peer-reviewed literature. However, the successful use of SD-OCT in routine clinical use depends upon the diagnostic sensitivity, biometric accuracy and reliability of the SD-OCT machines. This prospective, comparative, observational study aims to evaluate the imaging quality and diagnostic performance of two commercially available SD-OCT machines for both the anterior and posterior segment of the eye.

Interventions

None listed

Sponsors

Augenabteilung Allgemeines Krankenhaus Linz
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 21 and older * Normal eyes or * Eyes with corneal disease: Subjects that have any of the following conditions 1. Corneal dystrophy or degeneration 2. Corneal scarring 3. Corneal ulcer 4. Corneal injury 5. Keratoconus 6. Patients who had undergone corneal surgery 7. Patients with other corneal disease or - Eyes with retinal disease: Subjects that have any of the following conditions: 1. Diabetic macular edema 2. Cystoid macular edema 3. Age related macular degeneration 4. Retinal vascular disorders (e.g. retinal artery occlusion) 5. Epiretinal membrane 6. Choroidal nevus 7. Macular hole 8. Patients who had undergone retinal surgery 9. Patients with other retinal disease or * Eyes with glaucoma * Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant. AND \- Written informed consent prior to recruitment

Exclusion criteria

Any of the following will exclude a subject from the study: * Patients who are not able to cooperate or with insufficient ability to fixate (tremor, nystagmus) * Pregnancy (pregnancy test will be taken in women of reproductive age before enrolment into the trial)

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity as the proportion of anatomical structures that are detectable with the two instruments6 monthsAnatomical structures include e.g. sublayers of the cornea, sublayers of the retina, retinal vessels etc.

Secondary

MeasureTime frameDescription
Corneal sublayer thickness (µm) and retinal sublayer thickness (µm) obtained with the two study instruments6 monthsComparability is analyzed between various biometric values obtained with the two instruments and typical indices of comparability are produced (e.g. intraclass correlation coefficient)
Corneal sublayer thickness and retinal sublayer thickness obtained with the two study instruments6 monthsRepeatability for various biometric values obtained with the two instruments is analyzed and typical indices of repeatability are produced (e.g. coefficient of variation)

Countries

Austria

Contacts

Primary ContactNikolaus Luft, MD
nikolaus.luft@akh.linz.at+43 732 7806

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026